VONOPROZAN
Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in IndiaSun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug...
Torrent Pharma signs non-exclusive patent licensing pact with Takeda Pharma for VonoprazanA 2019 study published by the Indian Journal of Gastroenterology revealed that the prevalence of GERD in the Indian population is around 8....
- Load More